Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Cancer Monoclonal Antibodies Market 2017 Share, Trend, Segmentation And Forecast To 2021

Thursday, February 23, 2017 23:45
% of readers think this story is Fact. Add your two cents.

(Before It's News)

The analysts forecast the global cancer monoclonal antibodies market to grow at a CAGR of 10.86% during the period 2017-2021.

The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics.

Download Sample Report @ https://marketreportscenter.com/request-sample/488045

Covered in this report

The report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded cancer mAbs and biosimilars used to treat cancer. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

The report, Global Cancer Monoclonal Antibodies Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• F. Hoffmann-La Roche
• Amgen
• Bristol-Myers Squibb
• Takeda Pharmaceuticals

To Get More Details For The Reports:  https://marketreportscenter.com/reports/488045/global-cancer-monoclonal-antibodies-market-2017-2021

 Other prominent vendors
• AbbVie
• ADC Therapeutics
• Agensys
• Argos Therapeutics
• Astellas Pharma
• AstraZeneca
• Bayer
• Biogen
• Biotech Pharmaceutical
• BioGenomics
• Boehringer Ingelheim
• Celldex Therapeutics
• Chugai Pharmaceutical
• CTI BioPharma
• Daiichi Sankyo
• Eli Lilly
• Fortress Biotech
• Genmab
• Immunomedics
• Intas Pharmaceuticals
• Janssen Biotech
• Kyowa Hakko Kirin
• Merck
• MedImmune
• Morphotek
• Neovii Biotech
• Novartis
• OncoMed Pharmaceuticals
• Pfizer
• Sanofi
• Seattle Genetics
• TG Therapeutics
• Xbiotech

Market driver
• Increase in demand for ADCs
• For a full, detailed list, view our report

Market challenge
• Complicated regulatory framework
• For a full, detailed list, view our report

Market trend
• Emergence of targeted and combination therapies
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

 Table of Contents

PART 01: Executive summary 

PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: mAbs: Overview
• Evolution of mAb therapeutics
• Conjugated cancer therapies using mAbs

PART 06: Timeline of mAbs for cancer 

PART 07: Pipeline portfolio
• List of Phase III pipeline molecules
• List of Phase II pipeline molecules
• List of Phase I pipeline molecules

PART 08: Market landscape
• Market overview
• Five forces analysis

PART 09: Market segmentation by type of mAbs
• Naked mAbs
• Conjugated mAbs

PART 10: Market segmentation by MOA
• Immune system suppressors
• Kill or inhibit malignant cells
• Angiogenesis inhibitors
• Radiation therapy to cancer cells
• Delivering chemotherapy to cancer cells

PART 11: Geographical segmentation
• Cancer mAbs market in Americas
• Cancer mAbs market in EMEA
• Cancer mAbs market in APAC

..…..Continued

Check Discount On This Report @ https://marketreportscenter.com/request-discount/488045

For more information, please visit https://marketreportscenter.com

For more information content with us;

Sam Collins

Market Reports Center 1-646-883-3044 (US)

info@marketreportscenter.com

https://marketreportscenter.com

Source: https://marketreportscenter.com/reports/488045/global-cancer-monoclonal-antibodies-market-2017-2021

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.